Maven Securities LTD Novartis Ag Transaction History

Maven Securities LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $1.13 Million - $1.58 Million	-16,000 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$75.4 - $92.8 $1.21 Million - $1.48 Million	16,000 New	16,000 $1.46 Million
Q1 2018 May 15, 2018	SELL	$70.39 - $84.15 $716,288 - $856,310	-10,176 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$72.33 - $77.64 $302,050 - $324,224	4,176 Added 69.6%	10,176 $860,000
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $444,840 - $463,620	6,000	6,000 $513,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.